STAT3 Genotypic Variant rs744166 and Increased Tyrosine Phosphorylation of STAT3 in IL-23 Responsive Innate Lymphoid Cells during Pathogenesis of Crohn\u27s Disease

Crohn\u27s disease (CD) results from dysregulated immune responses to gut microbiota in genetically susceptible individuals, affecting multiple areas of the gastrointestinal tract. Innate lymphoid cells (ILCs) are tissue-resident innate effector lymphocytes which play crucial roles in mucosal immune defense, tissue repair, and maintenance of homeostasis. The accumulation of IFN-γ-producing ILC1s and increased level of proinflammatory cytokines produced by ILCs has been observed in the inflamed terminal ileum of CD patients. To date, the precise mechanisms of ILC plasticity and gene regulatory pathways in ILCs remain unclear. Signal transducer and activator of transcription 3 (STAT3) regulates gene expression in a cell-specific, cytokine-dependent manner, involving multiple immune responses. This study proposes the positive correlation between the prevalence of STAT3 rs744166 risky allele A with the severity of disease in a cohort of 94 CD patients. In addition, the results suggest an increased STAT3 activity in the inflamed ileum of CD patients, compared to unaffected ileum sections. Notably, IL-23 triggers the differentiation of CD117+NKp44- ILC3s and induces the activation of STAT3 in both CD117+NKp44- and CD117-NKp44- ILC subsets, implying the involvement of STAT3 in the initiation of ILC plasticity. Moreover, carriage of STAT3 A risk allele exhibited a higher basal level of STAT3 tyrosine phosphorylation, and an increased IL-23 triggered the pSTAT3 level. We also demonstrated that there was no delayed dephosphorylation of STAT3 in ILCs of both A/A and G/G donors. Overall, the results of this study suggest that IL-23-induced activation of STAT3 in the CD117-NKp44- ILC1s involves in ILC1-to-ILC3 plasticity and a potential regulatory role of ILC1 function. Those genetically susceptible individuals carried STAT3 rs744166 risky allele appear to have higher basal and cytokine-stimulated activation of STAT3 signal, leading to prolonged inflammation and chronic relapse

On the temperature structure of the Galactic Centre cloud G0.253+0.016

We present a series of smoothed particle hydrodynamical models of G0.253+0.016 (also known as 'The Brick'), a very dense molecular cloud that lies close to the Galactic Centre. We explore how its gas and dust temperatures react as we vary the strength of both the interstellar radiation field (ISRF) and the cosmic ray ionisation rate (CRIR). As the physical extent of G0.253+0.016 along our line-of-sight is unknown, we consider two possibilities: one in which the longest axis is that measured in the plane of the sky (9.4 pc in length), and one in which it is along the line of sight, in which case we take it to be 17 pc. To recover the observed gas and dust temperatures, we find find that the ISRF must be around 1000 times the solar neighbourhood value, and the CRIR must be roughly 1E-14 /s, regardless of the geometries studied. For such high values of the CRIR, we find that cooling in the cloud's interior is dominated by neutral oxygen, in contrast to standard molecular clouds, which at the same densities are mainly cooled via CO. Our results suggest that the conditions near G0.253+0.016 are more extreme than those generally accepted for the inner 500 pc of the galaxy.Comment: 6 pages, 4 figures, 1 table, accepted for publication in ApJ Letter

Treatment with Y-27632, a ROCK Inhibitor, Increases the Proinvasive Nature of SW620 Cells on 3D Collagen Type 1 Matrix

The concept of using tissue density as a mechanism to diagnose a tumor has been around for centuries. However, this concept has not been sufficiently explored in a laboratory setting. Therefore, in this paper, we observed the effects of cell density and extracellular matrix (ECM) density on colon cancer invasion and proliferation using SW620 cells. We also attempted to inhibit ROCK-I to determine its effect on cell invasion and proliferation using standard molecular biology techniques and advanced imaging. Increasing cell seeding density resulted in a 2-fold increase in cell invasion as well as cell proliferation independent of treatment with Y-27632. Increasing collagen I scaffold density resulted in a 2.5-fold increase in cell proliferation while treatment with Y-27632 attenuated this effect although 1.5 fold increase in cell invasion was observed in ROCK inhibited samples. Intriguingly, ROCK inhibition also resulted in a 3.5-fold increase in cell invasion within 3D collagen scaffolds for cells seeded at lower densities. We show in this paper that ROCK-I inhibition leads to increased invasion within 3D collagen I microenvironments. This data suggests that although ROCK inhibitors have been used clinically to treat several medical conditions, its effect largely depends on the surrounding microenvironment

Higher Molecular Weight Polyethylene Glycol Increases Cell Proliferation While Improving Barrier Function in an In Vitro Colon Cancer Model

Polyethylene glycol (PEG) has been previously shown to protect against enteric pathogens and prevent colon cancer invasion. To determine if PEG could indeed protect against previously observed pro-invasive effects of commensal E. coli and EPEC, Caco-2 cells grown in an in vitro model of colon cancer were infected with strains of human commensal E. coli or EPEC and treated with 10% PEG 3350, PEG 8000, and PEG 20,000, respectively. At 24 hours after infection, MMP-1 and MMP-13 activities, cell cluster thickness, depth of invasion, and proliferation were determined using standard molecular biology techniques and advanced imaging. We found that higher molecular weight PEG, especially PEG 8000 and 20,000, regardless of bacterial infection, increased proliferation and depth of invasion although a decrease in cellular density and MMP-1 activity was also noted. Maximum proliferation and depth of invasion of Caco-2 cells was observed in scaffolds treated with a combination of commensal E. coli strain, HS4 and PEG 8000. In conclusion, we found that PEG 8000 increased cell proliferation and led to the preservation of cell density in cells treated with commensal bacteria. This is important, because the preservation of a proliferative response in colon cancer results in a more chemo-responsive tumor

Tracing the formation of molecular clouds via [CII], [CI] and CO emission

Our understanding of how molecular clouds form in the interstellar medium (ISM) would be greatly helped if we had a reliable observational tracer of the gas flows responsible for forming the clouds. Fine structure emission from singly ionized and neutral carbon ([C II], [C I]) and rotational line emission from CO are all observed to be associated with molecular clouds. However, it remains unclear whether any of these tracers can be used to study the inflow of gas on to an assembling cloud, or whether they primarily trace the cloud once it has already assembled. In this paper, we address this issue with the help of high-resolution simulations of molecular cloud formation that include a sophisticated treatment of the chemistry and thermal physics of the ISM. Our simulations demonstrate that both [C I] and CO emission trace gas that is predominantly molecular, with a density n ∼ 500–1000 cm−3, much larger than the density of the inflowing gas. [C II] traces lower density material (n ∼ 100 cm−3) that is mainly atomic at early times. A large fraction of the [C II] emission traces the same structures as the [C I] or CO emission, but some arises in the inflowing gas. Unfortunately, this emission is very faint and will be difficult to detect with current observational facilities, even for clouds situated in regions with an elevated interstellar radiation field

Seasonal variability of sediment controls of nitrogen cycling in an agricultural stream

Agricultural streams receive large inputs of nutrients, such as nitrate (NO3−) and ammonium (NH4+), which impact water quality and stream health. Streambed sediments are hotspots of biogeochemical reactivity, characterised by high rates of nutrient attenuation and denitrification. High concentrations of nitrous oxide (N2O) previously observed in stream sediments point to incomplete denitrification, with sediments acting as a potentially significant source of global N2O. We investigated the effect of sediment type and seasonal variation on denitrification and N2O production in the streambed of an agricultural UK stream. Denitrification was strongly controlled by sediment type, with sand-dominated sediments exhibiting potential rates of denitrification almost 10 times higher than those observed in gravel-dominated sediments (0.026 ± 0.004 N2O–N μg g−1 h−1 for sand-dominated and 0.003 ± 0.003 N2O–N μg g−1 h−1 for gravel-dominated). In-situ measurements supported this finding, with higher concentrations of NO3−, nitrite (NO2−) and N2O observed in the porewaters of gravel-dominated sediments. Denitrification varied substantially between seasons, with denitrification increasing from winter to autumn. Our results indicate highest NO3− reduction occurred in sand-dominated sediments whilst highest N2O concentrations occurred in gravel-dominated sediments. This suggests that finer-grained streambeds could play an important role in removing excess nitrogen from agricultural catchments without producing excess N2O

The extracellular matrix microtopography drives critical changes in cellular motility and Rho A activity in colon cancer cells

We have shown that the microtopography (mT) underlying colon cancer changes as a tumor de-differentiates. We distinguish the well-differentiated mT based on the increasing number of "pits" and poorly differentiated mT on the basis of increasing number of "posts." We investigated Rho A as a mechanosensing protein using mT features derived from those observed in the ECM of colon cancer. We evaluated Rho A activity in less-tumorogenic (Caco-2 E) and more tumorigenic (SW620) colon cancer cell-lines on microfabricated pits and posts at 2.5 μm diameter and 200 nm depth/height. In Caco-2 E cells, we observed a decrease in Rho A activity as well as in the ratio of G/F actin on surfaces with either pits or posts but despite this low activity, knockdown of Rho A led to a significant decrease in confined motility suggesting that while Rho A activity is reduced on these surfaces it still plays an important role in controlling cellular response to barriers. In SW620 cells, we observed that Rho A activity was greatest in cells plated on a post microtopography which led to increased cell motility, and an increase in actin cytoskeletal turnover

Endoscopic, radiologic, and histologic healing with vedolizumab in patients with active Crohn's disease

BACKGROUND & AIMS: Vedolizumab is a gut-selective monoclonal antibody for the treatment of moderately to severely active Crohn's disease (CD). We performed a prospective study of endoscopic, radiologic, and histologic healing in patients with CD who received vedolizumab therapy. METHODS: We performed a phase 3b, open-label, single-group study of 101 patients with at least 3 months of active CD (a CD Activity Index [CDAI] score of 220-450, a simple endoscopic score for CD [SES-CD] of 7 or more, 1 or more mucosal ulcerations [identified by endoscopy], and failure of conventional therapy) from March 2015 through December 2017. Among the patients enrolled, 54.5% had previous failure of 1 or more tumor necrosis factor (TNF) antagonists and 44.6% had severe endoscopic disease activity (SES-CD scores above 15) at baseline. Participants received vedolizumab (300 mg intravenously) at weeks 0, 2, and 6, and then every 8 weeks thereafter, for 26 weeks (primary study) or 52 weeks (substudy, 56 patients). The primary endpoint at week 26 was endoscopic remission (SES-CD score of 4 or less); other endpoints included endoscopic response (50% reduction in SES-CD), radiologic remission (magnetic resonance index of activity score below 7), and histologic response (modified global histologic disease activity score of 4 or less). RESULTS: At week 26, 11.9% of patients were in endoscopic remission (95% confidence interval [CI] 6.3-9.8); at week 52, 17.9% of the patients were in endoscopic remission (95% CI 8.9-30.4). Higher proportions of patients naïve to TNF antagonists achieved endoscopic remission than patients with TNF-antagonist-failure at weeks 26 and 52. Higher proportion of patients with moderate CD (SES-CD scores, 7-15) achieved endoscopic remission at weeks 26 and 52 than patients with severe CD (SES-CD scores above 15). The proportion of patients with complete mucosal healing increased over time, with greater rates of healing in the colon than in the ileum. Remission was detected by magnetic resonance enterography in 21.9% of patients at week 26 (95% CI 9.3-40.0) and in 38.1% at week 52 (95% CI 18.1-61.6). At week 26, 24.4% of patients had a histologic response in the colon (95% CI 15.3-35.4) and 28.3% of patients had a histologic response in the ileum (95% CI 17.5-41.4). At week 52, 20.5% of patients had a histologic response in the colon (95% CI 9.8-35.3) and 34.3% of patients had a histologic response in the ileum (95% CI 19.1-52.2). There were no notable safety issues, including worsening of extraintestinal manifestations. CONCLUSIONS: In a phase 3b trial, we found that 26 and 52 weeks of treatment with vedolizumab (300 mg, at weeks 0, 2, and 6, and then every 8 weeks thereafter) induces endoscopic, radiologic, and histologic healing in patients with moderately to severely active CD. ClinicalTrials.gov no: NCT02425111. ispartof: GASTROENTEROLOGY vol:157 issue:4 pages:1007-+ ispartof: location:United States status: publishe